Picard Medical (PMI) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for Picard Medical (PMI).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||
Total Revenue | 1.15M (+15.00%) | 1.00M (-15.97%) | 1.19M (-44.13%) | 2.13M (+243.55%) | 620K (-78.01%) | 2.82M (+220.45%) | 880K (+27.54%) | 690K | - |
Cost Of Revenue | 880K (+49.15%) | 590K (-55.30%) | 1.32M (-41.59%) | 2.26M (+130.61%) | 980K (-47.59%) | 1.87M (+20.65%) | 1.55M (+43.52%) | 1.08M | - |
Costof Goods And Services Sold | 880K (+49.15%) | 590K (-55.30%) | 1.32M (-41.59%) | 2.26M (+130.61%) | 980K (-47.59%) | 1.87M (+20.65%) | 1.55M (+43.52%) | 1.08M | - |
Gross Profit | 280K (-31.71%) | 410K | -130.00K (0.00%) | -130.00K (-63.89%) | -360.00K | 940K | -670.00K (+76.32%) | -380.00K | - |
Operating Expenses | |||||||||
Research And Development | 1.90M (+245.45%) | 550K (-42.11%) | 950K (+28.38%) | 740K (-8.64%) | 810K (-45.27%) | 1.48M (+54.17%) | 960K (+2.13%) | 940K | - |
Selling General And Administrative | 2.89M (+0.70%) | 2.87M (+19.09%) | 2.41M (-9.06%) | 2.65M (+27.40%) | 2.08M (-57.64%) | 4.91M (+74.73%) | 2.81M (+12.40%) | 2.50M | - |
Operating Expenses | 4.79M (+40.47%) | 3.41M (+1.49%) | 3.36M (-0.88%) | 3.39M (+17.30%) | 2.89M (-54.77%) | 6.39M (+69.50%) | 3.77M (+9.59%) | 3.44M | - |
Depreciation And Amortization | 50K | -320.00K | - | 440K (+1000.00%) | 40K (-82.61%) | 230K | - | - | - |
Operating Income | |||||||||
Operating Income | -4.51M (+50.33%) | -3.00M (-14.04%) | -3.49M (-0.85%) | -3.52M (+8.31%) | -3.25M (-40.26%) | -5.44M (+22.52%) | -4.44M (+16.23%) | -3.82M | - |
Ebit | -4.51M (+50.33%) | -3.00M (-14.04%) | -3.49M (-0.85%) | -3.52M (+8.31%) | -3.25M (-6.88%) | -3.49M (-21.40%) | -4.44M (+16.23%) | -3.82M (+95.90%) | -1.95M |
EBITDA | -4.46M | 3.61M | -10.43M (+238.64%) | -3.08M (-3.75%) | -3.20M (+122.22%) | -1.44M (-76.81%) | -6.21M (+60.05%) | -3.88M (+98.97%) | -1.95M |
Other Income / Expenses | |||||||||
Interest Expense | - | -2.43M | - | 2.43M | - | -170.00K | - | 170K | - |
Net Interest Income | - | 2.43M | - | -2.43M | - | 170K | - | -170.00K | - |
Other Non Operating Income | -3.10M (-77.39%) | -13.71M (+97.55%) | -6.94M | - | -2.28M (-69.02%) | -7.36M (+318.18%) | -1.76M | - | - |
Net Income | |||||||||
Income Before Tax | -7.62M (+77.62%) | -4.29M (-58.87%) | -10.43M (+55.21%) | -6.72M (+21.52%) | -5.53M (-48.84%) | -10.81M (+74.07%) | -6.21M (+52.96%) | -4.06M | - |
Income Tax Expense | - | - | - | - | 30K | -10.00K | - | - | - |
Net Income From Continuing Operations | -7.62M (+77.62%) | -4.29M (-58.87%) | -10.43M (+55.21%) | -6.72M (+20.86%) | -5.56M (-37.10%) | -8.84M (+42.35%) | -6.21M (+52.96%) | -4.06M (+108.21%) | -1.95M |
Net Income | -7.62M (+77.62%) | -4.29M (-58.87%) | -10.43M (+55.21%) | -6.72M (+20.86%) | -5.56M (-37.10%) | -8.84M (+42.35%) | -6.21M (+52.96%) | -4.06M (+108.21%) | -1.95M |
Comprehensive Income Net Of Tax | -7.60M (-71.90%) | -27.05M (+158.60%) | -10.46M (+55.19%) | -6.74M (+21.22%) | -5.56M (-73.61%) | -21.07M (+239.84%) | -6.20M (+52.71%) | -4.06M | - |